The Soluble Form of Human Respiratory Syncytial Virus Attachment Protein Differs from the Membrane-Bound Form in Its Oligomeric State but Is Still Capable of Binding to Cell Surface Proteoglycans

Journal of Virology

Volumn 78, Issue 7, 2004, Pages 3524-3532

  Escribano Romero, Estela ^a   Rawling, Joanna ^a   García Barreno, Blanca ^a   Melero, José A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN; PROTEOGLYCAN; UNCLASSIFIED DRUG; VIRUS ATTACHMENT PROTEIN; VIRUS PROTEIN; HEPARIN LYASE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CHO CELL; CULTURE MEDIUM; FLOW CYTOMETRY; GENE DELETION; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN SECRETION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SUCROSE GRADIENT; VACCINIA VIRUS; VIRION; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS RECOMBINANT; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CHEMISTRY; DENSITY GRADIENT CENTRIFUGATION; GENETICS; HAMSTER; METABOLISM; MOLECULAR GENETICS; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SOLUBILITY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CENTRIFUGATION, DENSITY GRADIENT; CHO CELLS; CRICETINAE; GLYCOSAMINOGLYCANS; HEPARIN; HEPARIN LYASE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SOLUBILITY; VIRAL PROTEINS;

EID: 1842457772     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.7.3524-3532.2004     Document Type: Article

References (38)

1. Bembridge, G. P., R. García-Beato, J. A. Lopez, J. A. Melero, and G. Taylor. 1998. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J. Immunol. 161:2473-2480.
2. Blasco, R., and B. Moss. 1991. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by the deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65:5910-5920.
3. Blasco, R., and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
4. Brandenburg, A. H., H. J. Neijens, and A. D. Osterhaus. 2001. Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine 19:2679-2782.
5. Collins, P. L., and G. Mottet. 1992. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A. J. Gen. Virol. 73:849-863.
6. Collins, P. L., R. M. Chanock, and B. R. Murphy. 2001. Respiratory syncytial virus, p. 1443-1484. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
7. Crennell, S., T. Takimoto, A. Portner, and G. Taylor. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
8. Doreleijers, J. F., J. P. M. Langedijk, K. Hard, R. Boelens, J. A. C. Rullmann, W. M. Schaaper, J. T. van Oirschot, and R. Kaptein. 1996. Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus. Biochemistry 35:14684-14688.
9. Esko, J. D., T. E. Stewart, and W. H. Taylor. 1985. Animal cell mutants defective in Glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82:3197-3201.
10. Feldman, S. A., R. M. Hendry, and J. A. Beeler. 1999. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73:6610-6617.
11. García, O., M. Martín, J. Dopazo, J. Rabiza, S. Frabasile, J. Russi, M. Hortal, P. Perez-Breña, I. Martínez, B. García-Barreno, and J. A. Melero. 1994. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J. Virol. 68:5448-5459.
12. García-Barreno, B., C. Palomo, C. Peñas, T. Delgado, P. Perez-Breña, and J. A. Melero. 1989. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 63:925-932.
13. García-Beato, R., I. Martínez, C. Francí, F. X. Real, B. García-Barreno, and J. A. Melero. 1996. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein. Virology 221:301-309.
14. González-Reyes, L., M. B. Ruiz-Argüello, B. García-Barreno, L. Calder, J. A. López, J. P. Albar, J. J. Skehel, D. C. Wiley, and J. A. Melero. 2001. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl. Acad. Sci. USA 98:9859-9864.
15. Gorman, J. J., J. L. McKimm-Breschkin, B. S. Norton, and K. J. Barnham. 2001. Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein. J. Biol. Chem. 276:38988-38994.
16. Hallak, L. K., P. L. Collins, W. Knudson, and M. E. Peeples. 2000. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271:264-275.
17. Hallak, L. K., D. Spillmann, P. L. Collins, and M. E. Peeples. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:10508-10513.
18. Hendricks, D. A., K. Baradaran, K. McIntosh, and J. L. Patterson. 1987. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J. Gen. Virol. 68:1705-1714.
19. Hendricks, D. A., K. McIntosh, and J. L. Patterson. 1988. Further characterisation of the soluble form of the G glycoprotein of respiratory syncytial virus. J. Virol. 62:2228-2233.
20. Johnson, P. R., M. K. Spriggs, R. A. Olmsted, and P. L. Collins. 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA 84:5625-5629.
21. Krusat, T., and H. J. Streckert. 1997. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1247-1254.
22. Langedijk, J. P. M., B. L. de Groot, J. C. Berendsen, and J. T. van Oirschot. 1998. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology 243:293-302.
23. Levine, S., R. Klaiber-Franco, and P. R. Paradiso. 1987. Demonstration that the glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:2521-2524.
24. Lidholt, K., J. L. Weinke, C. S. Kiser, F. N. Lugemwa, K. J. Bame, S. Cheifetz, J. Massagué, U. Lindahl, and J. D. Esko. 1992. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. USA 89:2267-2271.
25. Martínez, I., J. Dopazo, and J. A. Melero. 1997. Antigenic structure of respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 78:2419-2429.
26. Martínez, I., and J. A. Melero. 2000. Binding of human respiratory syncytial virus to cells: implication of sulphated cell surface proteoglycans. J. Gen. Virol. 81:2715-2722.
27. McGinnes, L. W., and T. G. Morrison. 1994. The role of individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. Virology 200:470-483.
28. Melero, J. A., B. García-Barreno, I. Martínez, C. R. Pringle, and P. A. Cane. 1997. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J. Gen. Virol. 78:2411-2418.
29. Mok, J. Y., and H. Simpson. 1982. Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study. Br. Med. J. 285:333-337.
30. Pullen, C. R., and E. N. Hey. 1982. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br. Med. J. 284:1665-1669.
31. Roberts, S. R., D. Lichtenstein, L. A. Ball, and G. W. Wertz. 1994. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein are synthesised from alternative initiation codons. J. Virol. 68:4538-4546.
32. Satake, M., J. E. Coligan, N. Elango, E. Norrby, and S. Venkatesan. 1985. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res. 13:7795-7812.
33. Shields, B., J. Mills, R. Ghildyal, P. Gooley, and J. Meanger. 2003. Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells. Arch. Virol. 148:1987-2003.
34. Techaarpornkul, S., N. Barretto, and M. E. Peeples. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75:6825-6834.
35. Techaarpornkul, S., P. L. Collins, and M. E. Peeples. 2002. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294:296-304.
36. Teng, M. N., S. S. Whitehead, and P. L. Collins. 2001. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289:283-296.
37. Walsh, E. E., and J. Hruska. 1983. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J. Virol. 47:171-177.
38. Wertz, G. W., P. L. Collins, Y. Hang, C. Gruber, S. Levine, and L. A. Ball. 1985. Nucleotide sequence of the G protein of human respiratory syncytial virus reveals an unusual type of membrane protein. Proc. Natl. Acad. Sci. USA 82:4075-4079.